Oxygenta Pharmaceutical Ltd - Board Meeting Outcome for Submission Of Audited Financial Results For The Quarter And Year Ended 31St March, 2023

The Board at its meeting held today, i.e., Tuesday, 30th May, 2023, transacted inter-alia, the following businesses: 1. Financial Results: The Board approved the Audited Financial Results for the quarter and year ended 31st March, 2023. In this regard please find the enclosed: ? Audited Financial Results of the Company for the quarter and year ended 31st March, 2023 ? Auditor's report in respect of the Audited Financial Results of the Company for the quarter and year ended 31st March, 2023 ? Declaration pursuant to Regulation 33(3)(d) of Listing Regulations in terms of the audit reports with unmodified opinion. The meeting of Board of Directors of the Company commenced at 03:00 P.M and concluded at 05.35 P.M.